Robert Califf - Net Worth and Insider Trading

Robert Califf Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Robert Califf owns 3 companies in total, including Cytokinetics Inc (CYTK) , Portola Pharmaceuticals Inc (PTLA) , and Centessa Pharmaceuticals PLC (CNTA) .

Click here to see the complete history of Robert Califf’s form 4 insider trades.

Insider Ownership Summary of Robert Califf

Ticker	Comapny	Transaction Date	Type of Owner
CYTK	Cytokinetics Inc	2018-02-08	director
PTLA	Portola Pharmaceuticals Inc	2014-06-27	director
CNTA	Centessa Pharmaceuticals PLC	2021-05-27	director

Robert Califf Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Robert Califf Ownership Network

Ownership Network List of Robert Califf

No Data

Ownership Network Relation of Robert Califf

Robert Califf Owned Company Details

What does Cytokinetics Inc do?

Who are the key executives at Cytokinetics Inc?

Robert Califf is the director of Cytokinetics Inc. Other key executives at Cytokinetics Inc include SVP Research & Early Dev Fady Ibraham Malik , EVP & Corp. Development & CBO Robert I Blum , and VP & Chief Accounting Officer Robert Wong .

Cytokinetics Inc (CYTK) Insider Trades Summary

Over the past 18 months, Robert Califf made no insider transaction in Cytokinetics Inc (CYTK). Other recent insider transactions involving Cytokinetics Inc (CYTK) include a net sale of 373,500 shares made by Robert I Blum , a net sale of 183,194 shares made by Fady Ibraham Malik , and a net sale of 40,000 shares made by B Lynne Parshall .

In summary, during the past 3 months, insiders sold 137,437 shares of Cytokinetics Inc (CYTK) in total and bought 0 shares, with a net sale of 137,437 shares. During the past 18 months, 658,744 shares of Cytokinetics Inc (CYTK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 658,744 shares.

Cytokinetics Inc (CYTK)'s detailed insider trading history can be found in Insider Trading Tracker table.

Cytokinetics Inc Insider Transactions

No Available Data

What does Portola Pharmaceuticals Inc do?

Who are the key executives at Portola Pharmaceuticals Inc?

Robert Califf is the director of Portola Pharmaceuticals Inc. Other key executives at Portola Pharmaceuticals Inc include EVP & General Counsel John B Moriarty , EVP and CFO Mardi Dier , and EVP & CMO Rajiv Patni .

Portola Pharmaceuticals Inc (PTLA) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Portola Pharmaceuticals Inc (PTLA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Portola Pharmaceuticals Inc (PTLA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Portola Pharmaceuticals Inc (PTLA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Portola Pharmaceuticals Inc Insider Transactions

No Available Data

What does Centessa Pharmaceuticals PLC do?

Who are the key executives at Centessa Pharmaceuticals PLC?

Robert Califf is the director of Centessa Pharmaceuticals PLC. Other key executives at Centessa Pharmaceuticals PLC include director & Chief Executive Officer Saurabh Saha , Chief Financial Officer Gregory M Weinhoff , and Chief People Officer Karen M. Anderson .

Centessa Pharmaceuticals PLC (CNTA) Insider Trades Summary

Over the past 18 months, Robert Califf made no insider transaction in Centessa Pharmaceuticals PLC (CNTA). Other recent insider transactions involving Centessa Pharmaceuticals PLC (CNTA) include a net sale of 285,000 shares made by Saurabh Saha , a net sale of 85,000 shares made by Gregory M Weinhoff , and a net sale of 41,751 shares made by Harris Rotman .

In summary, during the past 3 months, insiders sold 370,000 shares of Centessa Pharmaceuticals PLC (CNTA) in total and bought 0 shares, with a net sale of 370,000 shares. During the past 18 months, 484,211 shares of Centessa Pharmaceuticals PLC (CNTA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 484,211 shares.

Centessa Pharmaceuticals PLC (CNTA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Centessa Pharmaceuticals PLC Insider Transactions

No Available Data

Robert Califf Mailing Address

Above is the net worth, insider trading, and ownership report for Robert Califf. You might contact Robert Califf via mailing address: Portola Pharmaceuticals, Inc., 270 East Grand Avenue, South San Francisco Ca 94080.

Discussions on Robert Califf

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.